HTG Molecular Diagnostics Inc. Daily Stock Analysis

Daily Stock Analysis, HTGM, HTG Molecular Diagnostics Inc, priceseries

HTG Molecular Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
1.79
Close
1.77
High
1.80
Low
1.65
Previous Close
1.80
Daily Price Gain
-0.03
YTD High
5.68
YTD High Date
Jan 3, 2022
YTD Low
1.65
YTD Low Date
Mar 7, 2022
YTD Price Change
-3.74
YTD Gain
-67.88%
52 Week High
6.98
52 Week High Date
Aug 30, 2021
52 Week Low
1.65
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-3.87
52 Week Gain
-68.62%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 1. 2017
47.55
Mar 2. 2017
50.02
1 Trading Days
5.21%
Link
LONG
Mar 3. 2017
42.15
Mar 7. 2017
51.68
2 Trading Days
22.60%
Link
LONG
Mar 23. 2017
58.95
Apr 4. 2017
91.60
8 Trading Days
55.39%
Link
LONG
Oct 10. 2017
28.35
Oct 31. 2017
35.47
15 Trading Days
25.10%
Link
LONG
Dec 21. 2017
28.50
Jan 17. 2018
46.36
16 Trading Days
62.66%
Link
LONG
Feb 12. 2018
60.75
Feb 27. 2018
70.01
10 Trading Days
15.24%
Link
LONG
Aug 24. 2018
50.85
Sep 12. 2018
62.27
12 Trading Days
22.46%
Link
LONG
Oct 23. 2019
12.00
Nov 7. 2019
13.12
11 Trading Days
9.34%
Link
LONG
May 20. 2020
6.90
Jun 1. 2020
7.42
7 Trading Days
7.62%
Link
LONG
Jun 2. 2020
8.25
Jun 11. 2020
8.90
7 Trading Days
7.89%
Link
LONG
Jun 17. 2020
10.20
Jun 24. 2020
10.75
5 Trading Days
5.44%
Link
LONG
Sep 17. 2020
5.13
Sep 22. 2020
5.41
3 Trading Days
5.38%
Link
LONG
Nov 25. 2020
4.69
Dec 15. 2020
5.47
13 Trading Days
16.70%
Link
LONG
Jan 4. 2021
4.99
Jan 28. 2021
6.59
17 Trading Days
32.14%
Link
LONG
Jun 9. 2021
4.26
Jul 2. 2021
5.60
17 Trading Days
31.40%
Link
Company Information
Stock Symbol
HTGM
Exchange
NasdaqCM
Company URL
http://www.htgmolecular.com
Company Phone
877-289-2615
CEO
Timothy B. Johnson
Headquarters
Arizona
Business Address
3430 E. GLOBAL LOOP, TUCSON, AZ 85706
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001169987
About

HTG Molecular Diagnostics, Inc. provides molecular technology solutions. It offers products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform detects changes in gene expression levels; especially from formalin-fixed, paraffin-embedded tissue and other biological sample types. It also offers pharma and diagnostics services. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Description

HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading